SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-013570 to Kaya Holdings, Inc. (KAYS) (CIK 0001530746)

Kaya Holdings, Inc. (KAYS) (CIK 0001530746)
Date: Dec. 9, 2024 · CIK: 0001530746 · Accession: 0000000000-24-013570

AI Filing Summary & Sentiment

File numbers found in text: 333-283570

Date
December 9, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Kaya Holdings, Inc. (KAYS) (CIK 0001530746)

Letter

December 9, 2024 Craig Frank Chief Executive Officer Kaya Holdings, Inc. 915 Middle River Drive, Suite 316 Ft. Lauderdale, FL 33304 Re:Kaya Holdings, Inc. Registration Statement on Form S-1 Filed December 3, 2024 File No. 333-283570 Dear Craig Frank: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Dale S. Bergman, Esq.

Show Raw Text
December 9, 2024
Craig Frank
Chief Executive Officer
Kaya Holdings, Inc.
915 Middle River Drive, Suite 316
Ft. Lauderdale, FL 33304
Re:Kaya Holdings, Inc.
Registration Statement on Form S-1
Filed December 3, 2024
File No. 333-283570
Dear Craig Frank:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Dale S. Bergman, Esq.